JFD Brokers Logo
Waiting For AbbVie’s Earnings Report

Waiting For AbbVie’s Earnings Report

2021/02/03
12:43
Darius Anucauskas

Darius Anucauskas

JFD Research, Technical Analysis

Looking at the technical picture of the AbbVie Inc stock (NYSE: ABBV), we can see that after hitting the area near the 113.38 hurdle in January, the price drifted heavily to the downside. Currently, ABBV is balancing slightly above its key support area, at 101.55. At the same time, the stock is trading below a short-term tentative downside resistance line drawn from the high of January 20th. For now, we will take a neutral approach, as we also wait for the company’s earnings report, which is set to be released today, before the US opening bell.

If the stock goes ahead and breaks below that support area, at 101.55, this will confirm a forthcoming lower low, potentially opening the door for further declines. ABBV might then slide to the 98.64 hurdle, marked by the low of November 20th, which may provide a temporary hold-up. Even if the stock rebounds somewhat, as long as it continues to trade below the aforementioned downside line, the downside scenario might be the main one for now. Another drop could bring the share price below the 98.64 hurdle, possibly clearing the way towards the 96.29 obstacle, or to the 94.70 level, marked by the low of November 9th.

The RSI, although a bit flat, remains below 50. The MACD is still pointing lower, while sitting below zero and well below its trigger line. The two oscillators support the above-discussed scenario, as they show downside price momentum.

Alternatively, if the stock breaks the aforementioned downside line and then pushes above the 106.18 barrier, marked by the high of January 27th, that may invite more buyers back into the game, possibly clearing the way to some higher areas. ABBV could then travel to the 108.57 hurdle, marked by the low of January 26th, which might stall the uprise for a bit. That said, if the buying doesn’t stop there, the share price might easily drift to the 111.59 obstacle, or to the 113.38 level, marked by the highest point of January.  

AbbVie-Daily

Disclaimer:

The content we produce does not constitute investment advice or investment recommendation (should not be considered as such) and does not in any way constitute an invitation to acquire any financial instrument or product. The Group of Companies of JFD, its affiliates, agents, directors, officers or employees are not liable for any damages that may be caused by individual comments or statements by JFD analysts and assumes no liability with respect to the completeness and correctness of the content presented. The investor is solely responsible for the risk of his investment decisions. Accordingly, you should seek, if you consider appropriate, relevant independent professional advice on the investment considered. The analyses and comments presented do not include any consideration of your personal investment objectives, financial circumstances or needs. The content has not been prepared in accordance with the legal requirements for financial analyses and must therefore be viewed by the reader as marketing information. JFD prohibits the duplication or publication without explicit approval.

There are risks involved with trading of cash equities. Past performance is not indicative of future results. You should consider whether you can tolerate such losses before trading. Please read the full Risk Disclosure.

Copyright 2021 JFD Group Ltd.

 

Get in Touch with Us

Sign Up For Our Newsletter
Attention icon
Trade
Responsibly

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 59.18% of the retail investor accounts lose money when trading CFDs with JFD. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Seek independent advice if necessary and review our Risk Disclosure and Privacy Policy before opening an account.

JFD Group Ltd is a company incorporated in Cyprus under registration number HE 282265, with its registered office at 70 Kyrillou Loukareos, KAKOS PREMIER TOWER, 2nd Floor, 4156 Limassol, Cyprus. The Company is authorised and regulated by the Cyprus Securities and Exchange Commission (“CySEC”) under Licence No. 150/11 and operates in full compliance with the Markets in Financial Instruments Directive (MiFID II). “JFD Brokers” is a brand name and registered trademark owned and used by the JFD Group of Companies.

JFD Group Ltd is licensed to provide the investment services of reception and transmission of orders in relation to one or more financial instruments, execution of orders on behalf of clients, dealing on own account, portfolio management and investment advice. In addition, the Company is authorised to provide the ancillary services of safekeeping and administration of financial instruments, granting credits or loans in connection with one or more financial instruments, foreign exchange services linked to the provision of investment services, and investment research and financial analysis. Clients are strongly advised to read and fully understand the Terms and Conditions of JFD Group Ltd before engaging in any activity with the Company.

Access to the Company’s trading platform and investment services is strictly prohibited for individuals under the age of 18, or below the legal age of majority in their country of residence, and for any persons who are otherwise legally incapable of entering into binding contracts under applicable laws. In the case of legal entities, access is limited to those duly incorporated and authorised to enter into legally binding agreements under the laws of their jurisdiction of incorporation, formation or domiciliation.

JFD Group Ltd may only provide services to clients resident in the European Economic Area (EEA) or in jurisdictions where the Company holds the necessary legal authorisations to do so.

The provision of investment services is restricted for residents of certain countries, including but not limited to the United States of America, Russia, Belarus, Poland, Latvia, the Czech Republic, Moldova, Montenegro, Serbia, the United Kingdom and any other jurisdiction where domestic regulations prohibit such offerings.

To provide you with the best possible experience, this site uses cookies. By continuing to browse or by clicking "Accept All Cookies", you agree to the cookie usage. Find out more in our Privacy Policy.
More options

Risk Warning: 59.18% of retail investor accounts lose money when trading CFDs with this provider.CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money. Please consider our Risk Disclosure.